Integrated Quality Assurance Engagement - Phase 3
ID: 1719276-40
Potential Value
$2,000,000
Deal Value
$0
Stated Probability
25%
Days in Pipeline
96
Client
Crest Pharmaceutical Worldwide
Account
Synergy Security Network
City
Dallas
Region
USLI
Sub-Sector
SLED
Service Line
Consulting
Field of Play
Technology
Opportunity Sub-SL
Technology
Competency
AI and Data Transformation
Global Service Code
TEC-Intelligent Analytics Platform (20383)
Partner
Müller Sara
Pursuit Leader
Schmidt Priya
Open Date
Feb 6, 2026
Anticipated Win Date
May 7, 2026
Close Date
N/A
Description
Integrated Quality Assurance Engagement - Phase 3
Triage & Expected Value
Predicts likelihood of pursuit vs. decline
P(Pursue)
82.0%
Expected Value (EV = P(Pursue) × P(Win) × Value)
$1,612,153
Key Triage Drivers
Win Probability Models
P(Pursue)
82.0%
Model A: Planning
98.4%
Model B: Early Signal
94.0%
Stated Probability
25%
Includes deal age and timeline factors. Best for active pipeline management.
Win Probability
98.4%
Key Drivers
Plain English
The model a: planning estimates a high probability of winning (98%). Factors working in favor: brand new pursuit (vs renewal), recurring/additional sale. Factors working against: lead sales credit %.
Excludes timeline factors. Better for early-stage assessment.
Win Probability
94.0%
Key Drivers
Plain English
The model b: early signal estimates a high probability of winning (94%). Factors working in favor: brand new pursuit (vs renewal), opportunitytype additional sales opportunity, recurring/additional sale.